jonathon-kellerman

Actavis hires senior head from PwC

pharmafile | December 24, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Jonathon Kellerman, pwC 

Jonathon Kellerman has joined Ireland-based speciality pharma firm Actavis as its executive vice president and global chief compliance officer. 

Reporting directly to Brent Saunders who is the Dublin firm’s chief executive and president, Kellerman is a member of the Actavis executive leadership team.

Kellerman joins Actavis from PwC where he was a partner in its pharmaceutical and life sciences advisory practice, and takes extensive experience in compliance and sales and marketing performance improvement to the firm. 

Advertisement

He has also led major ‘rapid response’ organisational and business process improvement initiatives across business and support functions Actavis adds. Earlier in his career Kellerman worked in healthcare consulting for Zelenkofske Axelrod and in research for Blank Rome.

“Jonathon brings nearly 20 years of experience in helping companies integrate compliance into the value chain and establish a vision for the future of how to effectively manage global risk by focussing on innovative solutions in compliance strategy, operations and process,” says Saunders.  

Related Content

nigeria

Nigerian agency strongly contests that 70% of drugs are fake

Nigeria’s drug regulatory body has fiercely countered claims made by Chief Economist of PwC in …

shutterstock_138095450

AZ tops annual R&D spend in UK, Roche is greatest pharma spender worldwide

New findings of a report by PwC have revealed the biggest spenders in R&D worldwide …

gavel

Patently problematic? The impact of the Eli Lilly/Actavis intellectual property battle

The UK Supreme Court has sent shockwaves through the intellectual property world with its recent …

The Gateway to Local Adoption Series

Latest content